Beyond Burnout: Docs Decry ‘Moral Injury’ From Financial Pressures of Health Care
Via Kaiser Health News Dr. Keith Corl was working in a Las Vegas emergency room when a patient arrived with [...]
Clinerion, Datametrix Partner on RWD, RWE
Clinerion and Datametrix announced a new partnership in which the organizations will generate real-world evidence (RWE) insights using real-world data [...]
Dems Invite Insulin Affordability Advocates to State of the Union
A slate of Democratic legislators have invited insulin affordability activists as their guests to tonight's State of the Union address, [...]
Narayanan Talks RWD in Clinical Research
COTA Healthcare Vice President of Life Sciences Viraj Narayanan during a recent interview with the American Journal of Managed Care [...]
MAPS Announces Keynote Speaker Lineup for Miami Meeting
The Medical Affairs Professional Society (MAPS) announced its lineup of keynote speakers for its upcoming meeting set to kick off [...]
New Report Highlights Pricing, Reimbursement for Innovative Drugs
A new FirstWord report shifts the spotlight to pricing and reimbursement for innovative drugs in major non-U.S. markets. The report, [...]
Coalition of Private Employers Looks to Lobby Congress on Drug Prices
A new coalition of private employers, EmployersRx, is looking to lobby Congress in a bid to reduce drug prices, STAT [...]
ICER Finalizes Updates to Value Assessment Framework
The Institute for Clinical and Economic Review (ICER) on Jan. 31 published an updated version of its value assessment framework [...]
Article Highlights Progress of Japan’s HTA System
A recent article published in the Journal of Medical Economics looks at the progress of Japan's health technology assessment (HTA) [...]
FDA Finalizes Policies Around Gene Therapies
Forecasting a boom in the gene therapy landscape, the Food and Drug Administration (FDA) last week finalized a number of [...]
ICER Recommends Major Price Reductions for New Sickle Cell Drugs
The Institute for Clinical and Economic Review (ICER) in a draft report recommended significant price cuts for two sickle cell [...]
Thought Leaders Discuss Areas of Promise in Health Care
Seven health care thought leaders share what they feel are the areas of promise in the health care industry on [...]
CCC, Evidence Partners Announce Delivery Collaboration
Copyright Clearance Center and Evidence Partners are joining forces to offer integrated document delivery through CCC's cloud-based RightFind solution within [...]
Denmark Adopting QALY System for Hospital Drugs
Denmark is shifting to a new evaluation system for hospital drugs based on the quality-adjusted life year (QALY), according to [...]
MCRA Taps McDermott to Head RHEMA Division
Clinical research organization MCRA recently welcomed John McDermott as the senior director of its Reimbursement, Health Economics, and Market Access [...]
CVS Caremark Plan Looks to Nix Costs for Diabetes Drugs
CVS Caremark's newest option, RxZERO, looks to nix out-of-pocket costs for diabetes drugs through a number of strategies, including nudging [...]
MM&M Set to Release Pharma Marketing Trends in March
MM&M announced it would release its flagship report on marketing in the pharmaceutical industry in March. "The proprietary survey of [...]
New Guidance Enables States to Convert Medicaid Funding into Block Grant
A new initiative rolled out earlier this week by Centers for Medicare and Medicaid Services (CMS) aims to let states [...]
NICE Rejects Coverage of J&J’s Spravato
The U.K.'s National Institute for Health and Care Excellence (NICE) earlier this week rejected coverage of Johnson & Johnson's heavily-criticized [...]
ICER Hosts Meeting on Migraine Treatments
The Institute for Clinical and Economic Review (ICER) hosted a public meeting last week to discuss new treatments for migraines. [...]
Podcast Highlights MS Drug Prices, Football Injuries
A recent Neurology Podcast features a discussion with Dr. Daniel Hartung about his study on drug prices for multiple sclerosis. [...]
Report Puts Spotlight on Pharma Transparency
FirstWord Pharma in its "Pricing Transparency in Pharma" report explores the rising demand for increased transparency. The report highlights 10 [...]
Pearson: Patient Engagement is Key to Fixing ‘Broken’ System
The key first step to fixing the "broken" U.S. health care system is to overhaul how organizations engage with patients, [...]
Patient-Preference Data in Medical Devices to Take Center Stage at ISPOR-FDA Summit
An upcoming summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in conjunction with the Food and [...]
PhRMA Announces HEOR Funding Opportunities
The PhRMA Foundation announced it is accepting applications for up to $100,000 in fellowships and grants for health outcomes research. [...]